12:00 AM
 | 
Mar 29, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Elan, Vanguard regulatory update

The companies said that the FDA has accepted for filing the NDA for VGD's...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >